Comment by stefan_

For a company that tries exclusively to sell to people that are very far removed from the use (government), yet have onerous reporting standards for all spending (government), there sure is very little independent reporting on the efficacy of whatever it is they are even selling. Even the contract with NHS was heavily censored. So frankly I oppose it on that ground alone.